The goal of this single-arm pilot study is to test the TRIAL web application which is designed to reduce inequity in clinical trial enrollment among participants with acute leukemia. The application aims to facilitate access to clinical trials and reduce barriers for underrepresented groups.
The research study procedures include screening for eligibility and questionnaires.
Participation in this research study is expected to last about 14 weeks.
It is expected about 75 people will participate in this study.
The National Cancer Institute (NCI) and American Society of Clinical Oncology (ASCO) are providing funding for this study.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Age 18 or older
English speaking
Ability to understand and willingness to sign written informed consent
Clinical suspicion of acute leukemia
Admitted to DFCI-affiliated inpatient unit
You may not be if
Cognitive impairment rendering the individual unable to participate in beta testing
* This will be assessed by focused chart review and consultation with the patients' inpatient care team.
The following populations will be excluded: adults unable to consent, individuals who are not yet adults (infants, children, teenagers \<18 years old), prisoners.
Inability to participate in in-person application testing.
Patients who participated in alpha-testing through protocol 23-404 (Appendix A)
